Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -20.24x is 39% above its 5-year average of -32.97x, near the high end of its 5-year range (-551.11x–56.32x).
622.56% below its 12-month average of -2.80x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2026-06-30): -4.16x.
INTEREST COVERAGE RATIO
-20.24x
INTEREST COVERAGE RATIO AVG TTM
-2.80x
INTEREST COVERAGE RATIO AVG 3Y
-24.51x
INTEREST COVERAGE RATIO AVG 5Y
-32.97x
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-622.56%
CURRENT VS 3Y AVG
+17.44%
CURRENT VS 5Y AVG
+38.61%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-5.12x
median of 422 covered companies
CURRENT VS SECTOR MEDIAN
-295.70%
vs the sector median at left
Biofrontera Inc.
Market Cap
$11.61M
Interest Coverage Ratio
-20.24x
TTM Avg
-2.80x
3Y Avg
-24.51x
5Y Avg
-32.97x
Market Cap
$11.73M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$11.30M
Interest Coverage Ratio
-473.91x
TTM Avg
210.31x
3Y Avg
210.31x
5Y Avg
210.31x
Market Cap
$11.94M
Interest Coverage Ratio
-1171.55x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$11.28M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$11.17M
Interest Coverage Ratio
26.76x
TTM Avg
26.76x
3Y Avg
26.76x
5Y Avg
26.76x
Market Cap
$12.12M
Interest Coverage Ratio
N/A
TTM Avg
4.58x
3Y Avg
5.23x
5Y Avg
12.43x
Market Cap
$10.94M
Interest Coverage Ratio
-219.72x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Biofrontera Inc. (BFRI) | $11.61M | -20.24x | -2.80x | -24.51x | -32.97x |
| Phio Pharmaceuticals Corp. (PHIO)vs › | $11.73M | N/A | N/A | N/A | N/A |
| Kiora Pharmaceuticals, Inc. (KPRX)vs › | $11.30M | -473.91x | 210.31x | 210.31x | 210.31x |
| Bullfrog AI Holdings, Inc. Common Stock (BFRG)vs › | $11.94M | -1171.55x | N/A | N/A | N/A |
| Adial Pharmaceuticals, Inc. (ADIL)vs › | $11.28M | N/A | N/A | N/A | N/A |
| BioVie Inc. (BIVI)vs › | $11.20M | -1265.39x | N/A | N/A | N/A |
| Pluri Inc. (PLUR)vs › | $11.17M | 26.76x | 26.76x | 26.76x | 26.76x |
| IRIDEX Corporation (IRIX)vs › | $12.12M | N/A | 4.58x | 5.23x | 12.43x |
| CytoMed Therapeutics Limited (GDTC)vs › | $10.94M | -219.72x | N/A | N/A | N/A |
| Lisata Therapeutics, Inc. (LSTA)vs › | $10.93M | N/A | N/A | N/A | N/A |
Interest Coverage
-20.2x
Debt/Equity
1.26
Current Ratio
1.18
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | -4.16x |
| 2026-03-31 | 34.56x |
| 2025-12-31 | 56.32x |
| 2025-09-30 | -56.56x |
| 2025-06-30 | -44.17x |
| 2025-03-31 | -37.89x |
| 2024-12-31 | -31.13x |
| 2024-09-30 | -551.11x |
| 2024-06-30 | -8.18x |
| 2024-03-31 | -3.85x |
| 2023-12-31 | -16.59x |
| 2023-09-30 | -29.81x |
| 2023-06-30 | -71.89x |
| 2023-03-31 | -60.35x |
| 2022-12-31 | -61.09x |
| 2022-09-30 | -39.55x |
| 2022-06-30 | -67.52x |
| 2022-03-31 | -33.44x |
| 2021-12-31 | -20.43x |
| 2021-09-30 | -178.94x |
| 2021-06-30 | -41.43x |
| 2021-03-31 | -39.64x |
| 2020-12-31 | -0.25x |
| 2020-09-30 | -3.12x |
